Please assess the completion status of the following clinical trial:

Trial Title: Prolonged Monitoring to Detect Ventricular Arrhythmias in Presymptomatic Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Identification of a pathogenic mutation† categorized as associated or probably associated with ARVC~2. Failure to meet definite revised Task Force Criteria for ARVC. Mutation carriers by definition have a major criterion, so included patients may have 1 minor criteria, but would meet Task Force Criteria for ARVC with 2 minor criteria or 1 major criterion.~3. \< 200 PVCs / hour on screening Holter monitor~4. Age \> 2 years~Exclusion Criteria:~1. Implantable device in place (pacemaker, ICD)~2. Age \< 2 years~3. Mutation represents a variant of unknown significance with reasonable probability that it may not be disease causing~4. Non-sustained ventricular tachycardia on screening Holter monitor (≥8 beats \> 100 bpm) and/or ≥ 200 PVCs / hour~5. Previous syncope or palpitations attributed to ARVC by the site investigator~6. Meets definite revised Task Force Criteria for ARVC (≥2 minor criteria and/or ≥1 additional major criterion). These ARVC patients who do not have an implanted device (ICD or pacemaker) will be included in a parallel voluntary registry separate from the study.

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Presymptomatic ARVC gene carriers (Type: None): ARVC gene positive patients without manifest ARVC after standard screening clinical testing.

Based on this trial design, predict the completion outcome and termination type (if applicable).